/

UK approves ‘next generation’ COVID-19 vaccine targeting Omicron variants

Clinical trial shows eight-fold antibody increase.

Image of a Moderna Spikevax COVID-19 vaccine vial
Credit: Miguel Tremblay (CC BY-SA 4.0)
Exit mobile version